Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST vs ROMIPLOSTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFLUMILAST vs ROMIPLOSTIM: Safety Overview

Metric ROFLUMILAST ROMIPLOSTIM
Total FAERS Reports 2,700 7,510
Deaths Reported 645 865
Death Rate 23.9% 11.5%
Hospitalizations 625 1,812
Average Patient Age 68.8 yrs 56.7 yrs
% Female Patients 56.3% 55.7%
FDA Approval Date Apr 17, 2023 N/A
Manufacturer Aurobindo Pharma Limited Amgen, Inc
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription